Washington, D.C. – Today, at the request of Congressman Brian Fitzpatrick (PA-01), Senator Pat Toomey, and Senator Bob Casey, the White House Office of National Drug Control Policy (ONDCP) designated Bucks County as a High Intensity Drug Trafficking Area (HIDTA). Fitzpatrick received a call at 2:00pm this afternoon from James Carroll, Director of the U.S. Office of National Drug Control Policy, regarding this decision.
Washington, D.C.— Congressman Brian Fitzpatrick (PA-01), a former FBI Special Agent in New York City, today will join 9/11 First Responders and family members at the White House as President Donald Trump signs into law the Never Forget the Heroes: James Zadroga, Ray Pfeifer, and Luis Alvarez Permanent Authorization of the September 11th Victim Compensation Fund Act.
Washington, D.C. – Congressman Brian Fitzpatrick (PA-01) and Congresswoman Susan Wild (PA-07) introduced the Mental Health in Schools Excellence Program Act. This legislation addresses the critical shortage of mental health professionals, like school psychologists, social workers, and counselors.
Washington, D.C.– Congressman Brian Fitzpatrick (PA-01) and Congresswoman Susan Wild (PA-07) offered a bipartisan amendment to the FY 2020 National Defense Authorization Act (NDAA) to provide additional resources to wounded servicemembers and improve resources available to prevent and treat opioid use across Pennsylvania.
Washington, D.C. – Congressman Brian Fitzpatrick (PA-01) is proud to announce his support for and cosponsorship of H.R. 3073, the TICK Act. Introduced by Representative Chris Smith (NJ-04) and Representative Collin C. Peterson (MN-07), this legislation seeks to prevent the spread of tick-borne illness in the United States through data and scientific analysis.
Washington, D.C. – This week, Representative Brian Fitzpatrick (PA-01), Representative Jason Crow (CO-06), Representative Terri Sewell (AL-07), and Representative Ken Calvert (CA-42), launched the ALS Caucus.
The ALS Caucus will bring together members of Congress from both sides of the aisle to share experiences, exchange ideas, and work collaboratively to find a cure for amyotrophic lateral sclerosis (ALS). The caucus was formed with the help of I AM ALS and many ALS advocacy groups, including The ALS Association and others.
Today, Reps. Brian Fitzpatrick (PA-01), Lloyd Doggett (TX-35), Rosa DeLauro (CT-03), and Jan Schakowsky (IL-09) introduced the Medical Device Guardians Act which codifies an existing mandate of the American Medical Association’s Code of Medical Ethics, recognizing that physicians are in the best position to identify and report unsafe devices. Additionally, the bill adds physicians’ reports to the list of groups, such as hospitals, already protected from having their reporting to the FDA used against them in a civil case.
In light of the dramatic rise in devastating fentanyl overdose deaths, Congressman Brian Fitzpatrick, Chair of the Heroin and Opioid Task Force, and Reps. Max Rose (NY-11), French Hill (AR-02), and Anthony Brindisi (NY-22), today introduced the bipartisan Fentanyl Sanctions Act—the first-ever fentanyl sanctions effort in the House of Representatives—that would pressure the Chinese government to honor their commitment to make all fentanyl illegal and provide the United States with more tools and resources to go after illicit traffickers in China, Mexico, and other countries.
Today, Reps. Brian Fitzpatrick (PA-01) and Seth Moulton (MA-06) introduced the Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population (HEADs Up) Act of 2019.
The HEADs Up Act would direct the Health Services and Resources Administration to designate people with Intellectual and Developmental Disabilities as a Medically Underserved Population. The HSRA is the government agency that advocates for people who are cut off from quality health care by economics, geography or a medical vulnerability.
Reps. Brian Fitzpatrick (PA-01) and Dan Kildee (MI-05), co-chairs of the PFAS Task Force, joined Rep. Brendan Boyle (PA-02) to introduced bipartisan legislation, the Protect Drinking Water from PFAS Act of 2019, H.R. 2377, to require the U.S. Environmental Protection Agency (EPA) to set an enforceable, nationwide primary drinking water standard for PFAS contaminants, including PFOS and PFOA which have plagued the Philadelphia region. Currently, the EPA sets voluntary advisory guidelines, and postponed a long-anticipated determination of whether to set an enforceable standard.
